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Abstract
Background: Genetic and environmental risk factors and gene-environment interactions are linked to higher
likelihood of developing schizophrenia in accordance with the neurodevelopmental model of disease; little is
known about risk factors and early development in early-onset schizophrenia (EOS) and very early-onset
schizophrenia (VEOS).
Methods: We present a case-control study of a sample of 21 patients with EOS/VEOS and a control group of 21
patients with migraine, recruited from the Child Neuropsychiatry Unit, Department of Neurologic and Psychiatric
Science, University of Bari, Italy. The aim was to assess the statistical association between VEOS/EOS and family
history for psychiatric disorders, obstetric complications and childhood developmental abnormalities using 2 × 2
tables and a Chi Squared or Fisher test.
Results: The results show a statistical association between EOS/VEOS and schizophrenia and related disorders (P =
0.02) and personality disorders (P = 0.003) in relatives, and between EOS/VEOS and developmental abnormalities of
early relational skills (P = 0.008) and learning (P = 0.04); there is not a statistically relevant difference between cases
and controls (P > 0.05) for any obstetric complications (pre, peri and postpartum).
Conclusions: This study confirms the significant role of familial liability but not of obstetric complications in the
pathogenesis of VEOS/EOS; the association between childhood developmental abnormalities and EOS/VEOS
supports the neurodevelopmental model of disease.
Background
Early-onset schizophrenia (EOS), manifesting before the
age of 18 years, and very early-onset schizophrenia
(VEOS), developing before the age of 13 years, are con-
sidered more severe and uncommon variants of the
adult-onset disorder; these clinical forms may be related
to a greater vulnerability by reason of higher risk factors
for schizophrenia and may be preceded by more rele-
vant neurodevelopmental abnormalities than the adult
onset form of the illness [1-4].
The study of childhood-onset schizophrenia conducted
by the National Institute of Mental Health (NIMH)
revealed more severe premorbid neurodevelopmental
abnormalities, a higher rate of cytogenetic anomalies, and
a seemingly higher rate of familial schizophrenia spec-
trum disorders than in later onset cases; there was no
evidence of increased obstetric complications or environ-
mental stress [5,6]. Vourdas et al. found that develop-
mental deviance and premorbid abnormalities of social
interaction and language-related functions tend to lead
to a more precocious onset of schizophrenia [7].
On the other hand, information obtained by parents
about risk factors for schizophrenia and early neurode-
velopment should be more recent and more reliable for
children and adolescents patients than adult onset
patients; therefore retrospective studies could lead to
more consistent data in case of EOS and VEOS rather
than in case of adult onset schizophrenia.
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patients with EOS and VEOS; the control group was
composed of 21 non-psychiatric patients affected by
migraine, supposed to have a different pathogenesis for
the illness; comparison was made according to age and
gender. The aim of the study was the following:
1. To carry out a retrospective analysis of the fre-
quency and typology of familial liability for psychia-
tric disorder, obstetric complications and childhood
developmental abnormalities in the cases and
controls;
2. To verify statistical association between EOS/
VEOS and familial and environmental risk factors
and childhood developmental abnormalities with
respect to the control group.
Methods
a) Subjects
The study sample consisted of 21 patients of both sexes,
with a diagnosis of schizophrenia in accordance with the
general diagnostic criteria of the Diagnostic and Statisti-
cal Manual for Mental Disorders, IV Edition-Text Revi-
sion DSM IV-TR [8], with the onset of psychotic
symptoms before the age of 18 years (EOS) or before
the age of 13 years (VEOS). They were recruited over a
three-year period from the Child Neuropsychiatry Unit,
Department of Neurologic and Psychiatric Science, Uni-
versity of Bari, Italy.
The control sample consisted of 21 patients of both
sexes, with a diagnosis of migraine in accordance with
the International Classification of Headache Disorders-II
edition, ICHD-II [9], followed clinically over the last
year from the Child Neuropsychiatry Unit, Department
of Neurologic and Psychiatric Science, University of Bari
too. They were matched to the EOS/VEOS patients
according to age and gender; exclusion criteria were evi-
dence of a psychiatric comorbidity.
The study was approved by the local ethical commit-
tee; all the parents who were interviewed provided writ-
ten consent.
b) Assessment
The diagnosis of schizophrenia and migraine was made
by an experienced child neuropsychiatrist on the basis
of interviews with the child and the family, a review of
past clinical records and historical information, and
was supported by the Kiddie-Schedule for Affective
Disorders and Schizophrenia-Present and Lifetime Ver-
sion, K-SADS-PL [10] and Child Behaviour Checklist,
CBCL [11].
A comprehensive diagnostic assessment was made in
both cases and controls, including a physical, neurologi-
cal and psychological examination and an instrumental
evaluation by electroencephalograph (EEG) and brain
magnetic resonance images (MRI). All patients were stu-
died with Wechsler Intelligence Scale for Children-
Revised, WISC-R [12] for the evaluation of Intelligence
Quotient (IQ).
Data about a family history of psychiatric diseases
were collected using the family history interview method
[13]. At least one family member, usually one of the
parents, was interviewed to inquire about both first and
second-degree relatives; whenever possible at least one
other family member was also contacted to maximize
the accuracy of the information. A positive or negative
family history was used as a dichotomous indicator of
familial loading for schizophrenia and related disorders,
affective disorders, anxiety disorders, substances abuse/
dependence, personality disorders, and any unspecified
mental disorder.
After examining the relevant documents showing pre-
cocious environmental risk factors for schizophrenia
[14-22], a list was drawn up of the main obstetric com-
plications that may be involved in the development of
the disease. Three groups of complications were investi-
gated: prepartum complications (bleeding, diabetes, rhe-
sus incompatibility, preeclampsia, anemia, toxemia,
placental abruption, smoking, drinking or drug addic-
tion, any medicament taken, maternal infections, psy-
chological maternal stress, threatened premature
delivery), peripartum complications (birth weight < 2000
g, emergency cesarean section, fetal hypoxia or anoxia,
gestational age < 37 weeks or > 42 weeks, delivery by
forceps or with cord around neck, labour < 3 h or > 36
h), postpartum complications (drugs given during the
neonatal period, early infections, continued hospitaliza-
tion of the baby after the discharge of the mother).
Information about these precocious environmental risk
factors was collected by interviewing the parents and
examining birth records.
Using a modified version of Developmental Scale [7]
with addiction to collect other information, the parents
were also asked about the presence of any deviations in
neuropsychological development during the first few
years of life, with particular reference to the develop-
ment of motor skills, language abilities, autonomous
sphincter control, early relational skills, school progress,
c) Statistical analysis
To assess the correlations between VEOS/EOS and
familial liability, obstetric complications and childhood
developmental abnormalities 2 × 2 tables were con-
structed and a Chi Squared or Fisher test was calculated.
When it was possible, OR (Odds Ratio) and its 95% CI
(Confidential Interval) were reckoned. Chosen signifi-
cance level was selected as P < 0.05. Statistical analysis
was performed by Stata MP for Mac Os 10.
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a) Demographic and clinical features of cases and
controls
The main demographic features of cases and controls
are resumed in table 1.
In the study sample there were 5 cases of EOS and 16
cases of VEOS; the mean age of onset of psychotic
symptoms was 10 years. There was no significant differ-
ence in the mean age of onset according to gender (10
years for males, 11 years for females), although there
was a wider range in males, from 5 to 15 years as com-
pared to the female range from 9 to 14 years.
All the EOS/VEOS subjects presented with nonspecific
prodromic symptoms. In the great majority of cases
(80%) the onset of psychotic symptoms was gradual and
insidious. Manifest disturbances were mostly in the
form of negative symptoms(71%), followed by delusions
(43%) and disorganized behaviour (43%); in 33% of the
cases there were hallucinations, equally frequent visual
and auditory; disorganized speech was present in the
same percentage of 33%.
Further to DSM criteria, assessment of the intelligence
quotient showed that mild mental delay was present in
24% of the cases, while 9.5% had a borderline IQ.
EEG abnormalities were found in 38% of the cases, the
most common findings being focal slow activity and
focal paroxysmal activity (i.e. spikes, sharp waves or
complexes). However, no specific EEG pattern emerged.
A single case was affected by the clinical condition of
“epileptic encephalopathy with polymorphic crises”.
Nonspecific alterations to MRI were found in 24% of
the cases, consisting of mild gliotic damage probably
attributable to pre and perinatal parenchymal hypoxia.
In one case proton magnetic resonance spectroscopy
(1H-MRS) showed an elevated lipids peak in both fron-
tal regions with normal values of N-acetylaspartate
(NAA), creatine plus phosphocreatine (Cr) and choline
(Cho) and NAA/Cr and Cho/Cr ratios; the full clinical
and neuroimaging study of this patient is described in
Margari F. et al, 2008 [2]. In another patient 1H-MRS
showed a mild alteration to the Cho/Cr ratio due to an
increased choline peak of the white matter of the semi-
oval centers.
One of the females with a diagnosis of VEOS was
adopted, so it was not possible to collect data on familial
psychiatric disturbances and neither early environmental
damage.
All the controls showed a normal IQ; in none of them
EEG/MRI alterations were shown to occur.
b) Familial liability
The data collected on family history for psychiatric disor-
ders for both groups of cases and controls are presented
in table 2. As we expected, there was a significant statisti-
cal association between psychiatric disease in relatives
and risk for developing schizophrenia (OR: 6.5, 95% CI:
1.3-35.1; P = 0.0074). Specifically, there was a statistical
association between EOS/VEOS and schizophrenia and
related disorders (P = 0.02) and personality disorders (P
= 0.003) in relatives. Moreover we noted that in 50% of
the cases of EOS/VEOS familial liability was present in
both parents’ families; anxiety and personality disorders
were shown to affect only the probands’ parents; mood
disturbances, drug abuse and unspecified psychiatric dis-
turbances concerned both the parents and other relatives;
schizophrenia and other psychotic disturbances were
shown to affect second degree relatives only.
c) Obstetric complications
Exposure to early environmental risk factors had
occurred in 55% of the subjects with VEOS/EOS; the
detailed description of the obstetric complications
reported in the cases of VEOS/EOS with a history of
early exposure to environmental risks are resumed in
table 3. The 43% of the control patients with migraine
had a history of obstetric complications. The difference
between cases and controls was not statistically relevant
(P > 0.05) for any obstetric complications (prepartum,
peripartum and postpartum complications), as reported
in table 4.
d) Childhood developmental abnormalities
Childhood developmental abnormalities were present in
65% of the subjects with EOS/VEOS: the most com-
monly involved areas were school progress, reported in
46% of the cases and early relational skills, reported in
46% of the cases. In 31% of the cases disturbances in
the development of language abilities were observed,
and enuresis was present in the same percentage. No
problems of motor skills were recorded. There was a
significant statistical association between childhood
developmental abnormalities and EOS/VEOS (OR: 37.1,
95% CI: 3.8-1654.1; P < 0.001). Specifically, there was a
statistical association between EOS/VEOS and develop-
mental abnormalities of relational skills (P = 0.008) and
learning (P = 0.04). The data about childhood develop-
mental abnormalities are presented in table 5.





Mean age 11 11
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In accordance with neurodevelopmental studies, schizo-
phrenia can be seen as a disorder with age-dependent
clinical manifestations that in a minority of individuals
start during childhood [23-28]. Although the prevalence
of EOS has not been adequately studied, the American
Academy of Child and Adolescent Psychiatry suggest
that EOS, and especially VEOS, are predominantly
observed in males, with a ratio of approximately 2:1 and
that with increasing age, this ratio tends to even out [1].
In our sample there were no significant sex differences
as regards either prevalence or mean age of onset. Kon-
necke et al. have claimed that the difference in the age
of onset between men and women is considerably
reduced in the presence of a strong genetic vulnerability
to schizophrenia and a history of pre and perinatal com-
plications [29]. In 80% of our sample of children with
EOS and VEOS we found a familial history of psychia-
tric disorders with a statistically relevant difference
between cases and controls. This confirms the important
role of familial loading as a risk factor for schizophrenia,
being comparable to the data on adult onset forms
[30-32]. The first family study of childhood-onset schi-
zophrenia was published byA s a r n o we ta l ;t h e yf o u n d
that relatives of probands with childhood-onset disease
had an increased lifetime morbid risk for schizophrenia
and schizotypal personality disorder as compared to the
relatives of children and adolescents with attention defi-
cit hyperactivity disorder and to the relatives of commu-
nity comparison subjects [33]. Nicolson et al. found a
greater morbid risk for schizophrenia spectrum disor-
ders (schizophrenia, schizoaffective disorder, other non-
affective psychotic disorders, schizotypal personality
disorder, paranoid personality disorder) in the parents of
patients with childhood onset than with adult onset
schizophrenia and both these groups were at a higher
risk than the parents of community comparison sub-
jects. Nevertheless, in their study, schizophrenia was an
uncommon diagnosis in all three groups of parents; no
diagnosis of either a schizoaffective disorder or another
nonaffective psychotic disorder was present in any of
the groups; moreover the parents of patients with child-
hood onset schizophrenia had a greater morbid risk for
a schizotypal personality disorder than the other two
groups and for a paranoid personality disorder than the
parents of community comparison subjects [34]. In this
study we found that the relatives of VEOS/EOS patients
differed significantly from the relatives of control sub-
jects in terms of family history of schizophrenia and
related disorders and of personality disorders. As
reported by Nicolson et al., in this sample too, the par-
ents of VEOS/EOS patients had only diagnosis of per-
sonality disorders and never of schizophrenia and
related disorders. As reported in other studies on famil-
ial liability for schizophrenia, we found that EOS/VEOS
is associated with a specific increase in family history for
schizophrenia and related disorders as well as for per-
sonality disorders, rather than general psychopathology.
Furthermore, the different psychopathological expres-
sion between first and second degree relatives suggests
that we should widen our knowledge about the person-
ality of EOS/VEOS parents. As matter of fact psycho-
pathological traits such as suspiciousness, withdrawal,
social avoidance, introversion, diffidence, flattened affec-
tivity are likely to account for the phenotypical expres-
sion relevant to familial vulnerability to schizophrenia,
characterized by both genetic and environmental factors
[35,36].










Family history of psichiatric disorders 16 (80%) 8 (38%) 24 (41%) 6.5(1.3-35.1) 0.0074
Schizophrenia and related disorders 5 (25%) 0 5 (12%) ___ 0.0207
Affective disorders 5 (25%) 2 (9%) 7 (17%) 3.2(0.4-36.6) 0.1880
Anxiety disorders 6 (30%) 5 (24%) 11 (27%) 1.4(0.3-7.1) 0.6547
Personality disorders 7 (35%) 0 7 (35%) ___ 0.0029
Substance abuse/dependence 2 (10%) 0 2 (10%) ___ 0.2317
Unspcified mental disorders 3 (15%) 1 (4%) 4 (9%) 3.5(0.2-194.3) 0.2694
Table 3 Pre-, peri- and postpartum complications in EOS/VEOS subjects with history of obstetric complications
Prepartum Peripartum Postpartum
Bleeding 10% Emergency cesarean section 50% Drugs 75%
Placental abruption 20% Fetal hipoxia 67% Early infections 75%
Psychological maternal stress 30% Gestational age > 37 weeks 33% Continued hospitalization 25%
Threatened premature delivery 70% Delivery by forceps 17% ——— —
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of predisposition to schizophrenia, there is evidence of an
important environmental contribution [17,32]. Obstetric
complications are among the most studied environmental
indicators of risk for schizophrenia although discordant
data have also been reported about the effective pathoge-
netic role in schizophrenia disease also because current
methods of investigating the relationship between obste-
tric complication and schizophrenia are reaching the
limit of their usefulness [37,18,19,38,22]. The conse-
quences of obstetric complications lack diagnostic speci-
ficity according to the level of hypoxemic stress suffered
and to the genetic predisposition of the foetus [14,39].
There is poor consensus about the pathogenetic mechan-
isms through which pre and perinatal damage can favour
the development of schizophrenia. Rosso et al. proposed
a model whereby the neurotoxic effects of fetal hypoxia
can trigger early onset of schizophrenia due to premature
cortical synaptic pruning [21]. Our data show the pre-
sence of environmental risk factors in 55% of the sample,
a higher proportion than the literature data on the fre-
quency of obstetric complications in patients with adult
onset schizophrenia (7-20% according to Boog G [14],
21.5-31.7% according to Nicolson et al. [6]). Other
Authors have also supported this association between
obstetric complication and an increased risk for early
onset schizophrenia [15,20-22]. Moreover, most of the
obstetric complications reported in our sample were cor-
related to fetal hypoxia (bleeding, placental abruption,
threatened premature delivery, peripartum fetal hypoxia,
emergency cesarean section, forceps delivery). This not-
withstanding, as Ordonez et al. in 2005 [40], we didn’t
find either a relevant association between obstetric com-
plications and VEOS/EOS when compared the patients
to control subjects; then we can’ts u p p o r tt h er o l eo f
obstetric complications as risk factors of schizophrenia,
also when examined more specifically as pre-, peri- and
postpartum complications. On the other hand the nature
and strength of the association between obstetric compli-
cations and schizophrenia has been questioned yet [16]
and the hypothesis that exposure to obstetric complica-
tions may interact with a genetic liability and increased
the vulnerability to schizophrenia remains difficult to
assess [39].
Studies of adult onset schizophrenia have demon-
strated that developmental delay, early functional
impairment and aspecific psychopathologic symptoms
are often observed prior to the full emergence of psy-
chotic symptoms [24,41,26,27,42,43]. They may be con-
sidered as a part of a longitudinal psychotic phenotype
in which some aspects are already established in early
life; alternatively, the effects may reveal a greater vulner-
ability depending on exposure to further causes, but
which may also be susceptible to protective factors. It is
unclear whether neurodevelopmental abnormalities are
on the increase in patients with early onset schizophre-
nia, nor whether do they act to precipitate the earlier
onset of the disorder[24,31,7]. We found a significant
statistical association between childhood developmental
abnormalities and the risk for schizophrenia, particularly
affecting relational skills and learning. Moreover, about
one third of our sample showed a low IQ. The preva-
lence of mental disturbances is known to be approxi-
mately four-fold in mentally retarded subjects as
compared to the general population, although the data
on prevalence by single diagnostic category are less pre-
cise [44,45]. It is generally agreed that cognitive deficits
play an important role in the malfunctioning mechanism










Obstetric complications 11 (55%) 9 (43%) 20 (48%) 1.6(0.4-6.7) 0.4369
Prepartum 10 (50%) 7 (33%) 17 (41%) 2(0.5-8.5) 0.2789
Peripartum 6 (30%) 4 (20%) 10 (24%) 1.8(0.3-10.5) 0.4143
Postpartum 4 (20%) 0 4 (20%) ___ 0.0310










Childhood developmental abnormalities 13 (65%) 1 (4%) 14 (34%) 37.1(3.8-1654.0) 0.0000
motor skills 0 0 0 ___ ___
language abilities 5 (25%) 1 (4%) 6 (14%) 6.6(0.6-330.6) 0.0931
sphincter control 4 (20%) 0 4 (9%) ___ 0.0310
relational skills 6 (30%) 0 6 (14%) ___ 0.0066
school progress 6 (30%) 0 6 (14%) ___ 0.0086
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Page 5 of 7underlying the disorder [46].C o g n i t i v ed e f i c i t sh a v e
been documented in practically every domain, being
most pronounced in the areas of memory, attention and
executive functioning [47]. Low intelligence may be an
independent risk factor for schizophrenia rather than
the manifestation of a single underlying pathogenetic
process.
Conclusion
This study confirms the significant role of familial liabi-
lity in the pathogenesis of VEOS/EOS, and opens more
specific questions about the phenotypic patterns of
familial transmission. On the other hand the study
doesn’t confirm the association between obstetric com-
plications pre, peri and postpartum and VEOS/EOS.
Moreover the study shows a statistical association
between childhood developmental abnormalities and
EOS/VEOS, with particular reference to early relational
skills and cognitive ability, in support of the neurodeve-
lopmental model of disease.
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